Fusion Pharmaceuticals Inc (NASDAQ:FUSN) Receives $9 50 Consensus PT from Analysts etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) had its target price decreased by equities research analysts at Raymond James from $13.00 to $12.00 in a report issued on Monday, MarketBeat.com reports. The brokerage presently has an “outperform” rating on the stock. Raymond James’ target price would suggest a potential upside of 277.36% from the stock’s […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Analysts at Wedbush boosted their Q3 2023 EPS estimates for Fusion Pharmaceuticals in a note issued to investors on Wednesday, August 9th. Wedbush analyst D. Nierengarten now anticipates that the company will earn ($0.38) per share for the quarter, up from their prior estimate of ($0.43). The […]
Research Analysts Issue Forecasts for Fusion Pharmaceuticals Inc s Q3 2023 Earnings (NASDAQ:FUSN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc (NASDAQ:FUSN) Given Average Recommendation of Buy by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.